Company / Gross Margin
ResMed Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
59.4%
FY2025
5-year range
55.8% / 59.4%
FY2021-FY2025
Trend
+4.7%
vs FY2024
Sector context
#45 of 91
Health Care
What the data says
At 59.4%, ResMed's gross margin ranks #45 of 91 in the Health Care sector. Gross Margin remained relatively stable over the past 10 years, with values between 55.8% and 59.4%.
Based on SEC 10-K filings.
59.4% in FY2025 with a 5-year CAGR of +1.3%.
Improved from 55.8% to 59.4% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- +2.8pp
- 5-Year Change
- +1.3pp
- 10-Year Change
- -
Sector benchmark
#45 of 91 in Health CareTop 49% of 91This company 59.4% Sector average 53.8%
▼
+10.3% above sector average
Key checks
Key Insights
- In FY2025, gross margin increased 4.7% year-over-year.
- Currently 5.6pp above the Health Care sector average.
- Lowest gross margin in the period was in FY2023.
Company context
Key Data Points
- High Piotroski F-Score: 8/9 (strong financial health signals)
- Altman Z-Score 3.25 (safe zone, above 2.9 threshold)
- Strong profit margin: 27.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 59.4% | +4.7% |
| FY2024 | 56.7% | +1.6% |
| FY2023 | 55.8% | -1.4% |
| FY2022 | 56.6% | -1.7% |
| FY2021 | 57.5% | -1.0% |
| FY2020 | 58.1% | +1.3% |
| FY2019 | 57.3% | +0.5% |
| FY2018 | 57.0% | -1.9% |
| FY2017 | 58.1% | +0.3% |
| FY2016 | 58.0% | -3.7% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026